Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2026-02-25 @ 2:36 AM
Study NCT ID:
NCT00503750
Status:
COMPLETED
Last Update Posted:
2012-06-25
First Post:
2007-07-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
Sponsor:
Organization: